Clinical Trials
7
Active:1
Completed:3
Trial Phases
2 Phases
Phase 1:2
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (66.7%)Phase 1
2 (33.3%)Evaluating the Safety and Efficacy of TLD in Patients With COPD
Not Applicable
Not yet recruiting
- Conditions
- COPDChronic Obstructive Pulmonary Disease
- Interventions
- Device: Targeted Lung Denervation (TLD)Drug: Standard medical care
- First Posted Date
- 2025-07-04
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Nuvaira, Inc.
- Target Recruit Count
- 400
- Registration Number
- NCT07051707
Evaluation of the Safety and Efficacy of TLD in Patients with COPD
Not Applicable
Active, not recruiting
- Conditions
- COPD
- First Posted Date
- 2018-08-20
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Nuvaira, Inc.
- Target Recruit Count
- 464
- Registration Number
- NCT03639051
- Locations
- 🇺🇸
University of Alabama at Birmingham (UAB) Lung Health Center, Birmingham, Alabama, United States
🇺🇸HonorHealth, Phoenix, Arizona, United States
🇺🇸UC Davis, Sacramento, California, United States
Discovery of the Impact of Targeted Lung Denervation (TLD) on the Severe and Very Severe COPD Population
Withdrawn
- Conditions
- COPD
- First Posted Date
- 2017-07-11
- Last Posted Date
- 2019-02-18
- Lead Sponsor
- Nuvaira, Inc.
- Registration Number
- NCT03213080
Evaluating the Safety and Feasibility of TLD for the Treatment of Severe Asthma
Not Applicable
Terminated
- Conditions
- Asthma
- First Posted Date
- 2016-08-19
- Last Posted Date
- 2022-04-12
- Lead Sponsor
- Nuvaira, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT02872298
- Locations
- 🇫🇷
CHU de Grenoble, Grenoble, France
🇩🇪Thoraxklinik Heidelberg, Heidelberg, Germany
🇳🇱Academic Medical Center, Amsterdam, Netherlands
Targeted Lung Denervation for Patients With Moderate to Severe COPD
Not Applicable
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- First Posted Date
- 2014-02-10
- Last Posted Date
- 2022-04-13
- Lead Sponsor
- Nuvaira, Inc.
- Target Recruit Count
- 128
- Registration Number
- NCT02058459
- Locations
- 🇦🇹
AKH Allgemeines Krankenhaus der Stadt Linz GmbH, Linz, Austria
🇦🇹Otto-Wagner-Spital, Vienna, Austria
🇧🇪CHU Saint Pierre, Brussels, Belgium
- Prev
- 1
- 2
- Next
News
No news found